Immediate Impact
58 standout
Citing Papers
The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
Defining clinically useful biomarkers of immune checkpoint inhibitors in solid tumours
2024 Standout
Works of Tai-Jong Chao being referenced
Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma
2010
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Tai-Jong Chao | 30 | 18 | 32 | 94 | 63 | 8 | 227 | |
| Francesca Capelli | 37 | 19 | 8 | 68 | 62 | 13 | 218 | |
| Yuan‐Chin Amy Lee | 66 | 26 | 32 | 71 | 22 | 12 | 276 | |
| L. T. Hsiao | 68 | 13 | 6 | 97 | 59 | 12 | 240 | |
| Alessia Ferrarini | 11 | 34 | 6 | 81 | 45 | 6 | 262 | |
| Barbara Lei | 30 | 33 | 13 | 137 | 24 | 9 | 249 | |
| Carl Janssen | 16 | 25 | 53 | 79 | 20 | 7 | 244 | |
| Veronika Kanitz | 72 | 32 | 13 | 23 | 32 | 9 | 248 | |
| Anita Pathil‐Warth | 32 | 57 | 31 | 57 | 27 | 14 | 232 | |
| C. Camaris | 59 | 40 | 49 | 27 | 24 | 11 | 270 | |
| Philippe Kolly | 34 | 33 | 18 | 185 | 19 | 10 | 299 |
All Works
Loading papers...